Receptor News and Research

RSS

Study explores potential breast cancer benefits of neurokinin receptor antagonists

Neurokinin receptor (NKR) antagonists are already widely used for treating menopausal hot flashes, representing a highly effective nonhormone treatment.

20 Oct 2026

Could eating whey protein before meals help reduce blood sugar spikes?

A narrative review of 57 randomized trials found that milk and dairy products have inconsistent effects on long-term blood sugar control in adults with type 2 diabetes or prediabetes. Whey protein consumed before meals more consistently reduced short-term blood sugar spikes, but further research is needed to establish whether these benefits persist over time.

19 Oct 2026

Blood pressure drug losartan boosts metabolism by stimulating brown fat

Losartan, a drug commonly prescribed for high blood pressure, boosts brown adipose tissue or "brown fat" activity and enhances its metabolism, according to a preclinical study by Weill Cornell Medicine, Rockefeller University and Memorial Sloan Kettering Cancer Center researchers.

19 Oct 2026

invIOs publishes positive clinical data on CBL-B-silenced autologous cell therapy APN401 in peer-reviewed journal

invIOs GmbH (“invIOs”), a privately held biotechnology company developing innovative cancer immunotherapies, today announced the publication of new clinical data with its autologous PBMC (peripheral blood mononuclear cell) therapy APN401 in the peer-reviewed journal, Molecular Therapy Oncology.

16 Oct 2026

AI study of 101,000 patients links brown fat to heart and mental health

In a retrospective analysis of PET-CT records from 101,243 patients, researchers found that detectable brown fat was associated with lower prevalence of cardiometabolic and psychiatric conditions, while greater activity, particularly in the axillary region, was linked to more favourable metabolic outcomes. Medication screening identified losartan, which increased brown fat thermogenic activity in laboratory experiments and energy expenditure in mice, although its effects on human brown fat remain unproven.

15 Oct 2026

Light-activated experimental opioid eliminates dangerous side effects

Opioid painkillers are some of the strongest analgesic medicines, but they are also the riskiest owing to a range of side effects, including addiction.

15 Oct 2026

Heart failure alters bone marrow to promote harmful inflammation

Heart failure (HF) alters the bone marrow (BM), reducing protective cells that regulate inflammation, reports a study conducted at Science Tokyo.

15 Oct 2026

Losing weight is one thing. Keeping your muscle is another, experts say

The International Society of Sports Nutrition (ISSN) position stand concludes that sustained calorie restriction drives weight loss, while adequate protein intake and resistance training help preserve lean mass. Reviewing intermittent fasting, ketogenic diets, and other dietary approaches, the authors emphasize individualized nutrition plans, body composition, and sustainable weight management rather than rapid weight loss alone.

14 Oct 2026

Understanding how neutrophil signaling pathways disrupt the human intestinal barrier

The intestinal mucosal barrier separates the host from the gut lumen and is essential for systemic homeostasis.

14 Oct 2026

Common blood pressure drug boosts brown adipose tissue activity and metabolism

Scientists have discovered that the drug losartan, commonly prescribed for high blood pressure, boosts brown adipose tissue activity in mice, enhancing their metabolism.

14 Oct 2026

CSHL researchers find way to make immunotherapy effective against colorectal cancer

Colorectal cancer has become the leading cause of cancer-related death for people under 50. Its most common forms generally aren't treatable, either through conventional means like chemotherapy or newer immunotherapy drugs.

14 Oct 2026

Investigational knee injection targets cartilage loss in osteoarthritis patients

Keck Medicine of USC has launched a clinical trial testing the safety and tolerability of a new investigational treatment and its potential effects on preventing cartilage deterioration in people with knee osteoarthritis, the most common form of the disease.

14 Oct 2026

Chemists develop blueprint for designing powerful fluorescent materials for better disease detection

Chemists at the University of Bath have discovered how tiny molecular changes can transform the color and brightness of fluorescent probes based on the blue molecule azulene, paving the way for more powerful imaging tools for detecting diseases such as Alzheimer's, Parkinson’s and cancer.

14 Oct 2026

From turmeric to fenugreek, scientists examine nature’s potential role in diabetes care

A narrative review examined how curcumin, honey, culinary spices, and traditional remedies may influence oxidative stress, inflammation, mitochondrial function, and insulin signaling in diabetes. Although experimental research and some clinical trials suggest potential metabolic benefits, the authors emphasize that larger, well-controlled studies are needed to establish their effectiveness and safety alongside conventional treatments.

14 Oct 2026

Researchers uncover how metastatic colorectal cancer evades immune attack

Researchers at Hokkaido University, in collaboration with an international team of scientists led by the University of South Florida Health and Tampa General Hospital, have uncovered an important mechanism behind immune evasion in metastatic colorectal cancer (mCRC).

13 Oct 2026

Doctors avoided two common words when talking about weight with patients

Researchers analyzed 123 recorded primary care consultations involving adults with type 2 diabetes and elevated BMI, finding that weight was discussed in just 39% of visits. Clinicians avoided potentially stigmatizing terms such as "overweight" and "obesity," while weight-related conversations occurred more frequently among patients taking GLP-1 receptor agonists.

13 Oct 2026

FDA approves new Parkinson’s drug pioneered by UVA scientists

The federal Food and Drug Administration has approved a new Parkinson's disease drug that was based on research by UVA Health scientists.

13 Oct 2026

Review highlights EP4 receptor as target for inflammatory diseases

A review published in Genes & Diseases highlights the prostaglandin E2 receptor subtype 4 (EP4) as an important regulator of inflammation and a promising therapeutic target for a wide range of inflammatory and inflammation-related diseases.

12 Oct 2026

Stopping GLP-1 drugs often brings weight back. A small trial suggests ways to slow it

In a randomized pilot trial of 39 adults, researchers found that participants receiving medically tailored meals or Noom regained about 3.6% of their body weight over four months after stopping GLP-1 therapy, compared with about 11% under usual care. These exploratory findings suggest structured support may slow early weight regain, but the small sample and short follow-up leave lasting benefits uncertain.

11 Oct 2026

Nasal immune adjuvant protects mice against respiratory viruses for months

The COVID-19 pandemic showed the challenges of protecting populations when a new respiratory virus emerges.

9 Oct 2026

Receptor News and Research

Study explores potential breast cancer benefits of neurokinin receptor antagonists

Could eating whey protein before meals help reduce blood sugar spikes?

Blood pressure drug losartan boosts metabolism by stimulating brown fat

invIOs publishes positive clinical data on CBL-B-silenced autologous cell therapy APN401 in peer-reviewed journal

AI study of 101,000 patients links brown fat to heart and mental health

Light-activated experimental opioid eliminates dangerous side effects

Heart failure alters bone marrow to promote harmful inflammation

Losing weight is one thing. Keeping your muscle is another, experts say

Understanding how neutrophil signaling pathways disrupt the human intestinal barrier

Common blood pressure drug boosts brown adipose tissue activity and metabolism

CSHL researchers find way to make immunotherapy effective against colorectal cancer

Investigational knee injection targets cartilage loss in osteoarthritis patients

Chemists develop blueprint for designing powerful fluorescent materials for better disease detection

From turmeric to fenugreek, scientists examine nature’s potential role in diabetes care

Researchers uncover how metastatic colorectal cancer evades immune attack

Doctors avoided two common words when talking about weight with patients

FDA approves new Parkinson’s drug pioneered by UVA scientists

Review highlights EP4 receptor as target for inflammatory diseases

Stopping GLP-1 drugs often brings weight back. A small trial suggests ways to slow it

Nasal immune adjuvant protects mice against respiratory viruses for months

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News